Publication:
Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma.

dc.contributor.authorUnfried, Juan P
dc.contributor.authorMarín-Baquero, Mikel
dc.contributor.authorRivera-Calzada, Ángel
dc.contributor.authorRazquin, Nerea
dc.contributor.authorMartín-Cuevas, Eva M
dc.contributor.authorde Bragança, Sara
dc.contributor.authorAicart-Ramos, Clara
dc.contributor.authorMcCoy, Christopher
dc.contributor.authorPrats-Mari, Laura
dc.contributor.authorArribas-Bosacoma, Raquel
dc.contributor.authorLee, Linda
dc.contributor.authorCaruso, Stefano
dc.contributor.authorZucman-Rossi, Jessica
dc.contributor.authorSangro, Bruno
dc.contributor.authorWilliams, Gareth
dc.contributor.authorMoreno-Herrero, Fernando
dc.contributor.authorLlorca Blanco, Oscar Antonio
dc.contributor.authorLees-Miller, Susan P
dc.contributor.authorFortes, Puri
dc.contributor.authorLlorca, Oscar
dc.contributor.authorUnfried, Juan P.
dc.contributor.authorMartín-Cuevas, Eva M.
dc.contributor.authorLees-Miller, Susan P
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderLigue Nationale Contre le Cancer (Francia)
dc.contributor.funderNatural Sciences and Engineering Research Council of Canada (NSERC)es_ES
dc.contributor.funderCanada Foundation for Innovation
dc.contributor.funderAsociación Española Contra el Cáncer
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.contributor.funderUnited States Department of Health and Human Services
dc.date.accessioned2024-09-16T08:16:58Z
dc.date.available2024-09-16T08:16:58Z
dc.date.issued2021-10-01
dc.description.abstractLong noncoding RNAs (lncRNA) are emerging as key players in cancer as parts of poorly understood molecular mechanisms. Here, we investigated lncRNAs that play a role in hepatocellular carcinoma (HCC) and identified NIHCOLE, a novel lncRNA induced in HCC with oncogenic potential and a role in the ligation efficiency of DNA double-stranded breaks (DSB). NIHCOLE expression was associated with poor prognosis and survival of HCC patients. Depletion of NIHCOLE from HCC cells led to impaired proliferation and increased apoptosis. NIHCOLE deficiency led to accumulation of DNA damage due to a specific decrease in the activity of the nonhomologous end-joining (NHEJ) pathway of DSB repair. DNA damage induction in NIHCOLE-depleted cells further decreased HCC cell growth. NIHCOLE was associated with DSB markers and recruited several molecules of the Ku70/Ku80 heterodimer. Further, NIHCOLE putative structural domains supported stable multimeric complexes formed by several NHEJ factors including Ku70/80, APLF, XRCC4, and DNA ligase IV. NHEJ reconstitution assays showed that NIHCOLE promoted the ligation efficiency of blunt-ended DSBs. Collectively, these data show that NIHCOLE serves as a scaffold and facilitator of NHEJ machinery and confers an advantage to HCC cells, which could be exploited as a targetable vulnerability. SIGNIFICANCE: This study characterizes the role of lncRNA NIHCOLE in DNA repair and cellular fitness in HCC, thus implicating it as a therapeutic target.See related commentary by Barcena-Varela and Lujambio, p. 4899.es_ES
dc.description.peerreviewedNoes_ES
dc.description.sponsorshipThe authors particularly acknowledge the patients for their participation and the Biobank of the University of Navarra for its collaboration. They thank all members of the Fortes Lab for helpful discussions and Guillermo Serrano and Dr. Victor Segura from CIMA bioinformatics unit for excellent expert assistance. They thank R. Ye and Dr. Anne Vaahtokari for technical assistance, S. Fang (University of Calgary) for purification of XRCC4 and APLF, and Dr. Laurence H. Pearl (Genome Damage and Stability Centre, School of Life Sciences, University of Sussex) for providing X4L4 and Ku70/80 for some of the experiments in this work. The authors also thank the flow cytometry facility and the Arnie Charbonneau microscopy facility at Cumming School of Medicine, University of Calgary for expert assistance. The results shown here are in part based upon data generated by the TCGA Research Network (http://cancergenome.nih.gov/) 146146and by the GTEx Project (https://gtexportal.org/).Figures 3A and E and 7; Supplementary Fig. S3H were created with BioRender.com. This work was supported by the European FEDER funding (to the activities of the groups directed by P. Fortes, O. Llorca, and F. Moreno-Herrero) and grants from theMinistry of Economy and Competitiveness [SAF2015-70971-R to P. Fortes and BFU201783794-P (AEI/FEDER, UE) to F. Moreno-Herrero)]; MCIU/AEI/FEDER/UE (RTI2018-101759-B-I00 to P. Fortes), NIH program (CA92584 to S.P. Lees-Miller), Ligue National Contre le Cancer, ~Equipe Labellis~ee and ITMO Cancer: Consortium HETCOLI (to J. Zucman-Rossi), NIH program (P01CA092584 to G. Williams), NSERC (RGPIN-2018-04327 to G. Williams), and CFI (RCP-18-023-SEG to G. Williams), Gobierno de Navarra (33/2015 to P. Fortes), Scientific Foundation of the Spanish Association Against Cancer (AECC IDEAS20169FORT to P. Fortes); Fondo de Investigacion Sanitaria (PI19/00742 to B. Sangro), financed by the National Institute of Health Carlos III and FEDER. CNIO and CIBERehd are funded by the National Institute of Health Carlos III. J.P. Unfried was a recipient of a University of Navarra's Asociacion de Amigos fellowship. L. Prats-Mari is a recipient of a PFIS fellowship (FI20/00074) by the National Institute of Health Carlos III and FSE "Investing in Your Future." This work was also funded by grants from the Autonomous Region of Madrid (Tec4Bio-S2018/NMT-4443 and NanoBioCancerY2018/BIO-4747 to O. Llorca and F. Moreno-Herrero) and co-funded by the European Social Fund. F. Moreno-Herrero acknowledges support from the European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (grant agreement 681299). The GTEx Project was supported by the NIH and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.es_ES
dc.format.number19es_ES
dc.format.page4910es_ES
dc.format.volume81es_ES
dc.identifier.citationCancer Res . 2021 ;81(19):4910-4925.es_ES
dc.identifier.doi10.1158/0008-5472.CAN-21-0463es_ES
dc.identifier.e-issn1538-7445es_ES
dc.identifier.issn0008-5472es_ES
dc.identifier.journalCancer researches_ES
dc.identifier.pmchttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488005/pdf/nihms-1730416.pdf
dc.identifier.pubmedID34321241es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23088
dc.language.isoenges_ES
dc.publisherAmerican Association for Cancer Research (AACR)
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/EC/681299es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FI20/00074es_ES
dc.relation.publisherversionhttps://doi.org/10.1158/0008-5472.CAN-21-0463es_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Complejos Macromoleculares en la Respuesta a Daños en el DNAes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshDNA Breaks, Double-Strandedes_ES
dc.subject.meshBiomarkers, Tumores_ES
dc.subject.meshCarcinoma, Hepatocellulares_ES
dc.subject.meshCell Line, Tumores_ES
dc.subject.meshDNA End-Joining Repaires_ES
dc.subject.meshGene Expression Profilinges_ES
dc.subject.meshGene Expression Regulation, Neoplastices_ES
dc.subject.meshHigh-Throughput Nucleotide Sequencinges_ES
dc.subject.meshHumanses_ES
dc.subject.meshLiver Neoplasmses_ES
dc.subject.meshModels, Biologicales_ES
dc.subject.meshNucleic Acid Conformationes_ES
dc.subject.meshNucleotide Motifses_ES
dc.subject.meshPrognosises_ES
dc.subject.meshRNA, Long Noncodinges_ES
dc.titleLong Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma.es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionAOes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication63cfd8da-7c4d-43c3-a627-57b70f73572a
relation.isAuthorOfPublication.latestForDiscovery63cfd8da-7c4d-43c3-a627-57b70f73572a
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication77b2fc20-6311-4e46-98a7-83e46257b93b
relation.isFunderOfPublicationef5576d5-2a85-4ab7-8ca9-d1db9877f7cc
relation.isFunderOfPublication1adf2a4b-8a71-4689-84a7-cb9c568a2cfe
relation.isFunderOfPublication453a1189-9bca-4be8-8d60-695f50fe028b
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationcb2ee04a-8d42-4a64-b3f6-3c156f222b35
relation.isFunderOfPublication6081a0d0-d423-4510-b1af-a52eac0c92e4
relation.isFunderOfPublication.latestForDiscoveryefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isPublisherOfPublicationfeeb2648-1129-4dba-838d-68d8d9be6f57
relation.isPublisherOfPublication.latestForDiscoveryfeeb2648-1129-4dba-838d-68d8d9be6f57

Files